Cargando…
Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials (Galvano et al., J Bone Oncol 2019; 18:100252)
Autores principales: | Galvano, Antonio, Scaturro, Dalila, Bazan, Viviana, Letizia Mauro, Giulia, Russo, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385536/ https://www.ncbi.nlm.nih.gov/pubmed/32742917 http://dx.doi.org/10.1016/j.jbo.2020.100295 |
Ejemplares similares
-
Commentary to “Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials” (Galvano et al. J Bone Oncol 2019; 18:100252)
por: Gonzalez-Rodriguez, Elena, et al.
Publicado: (2020) -
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials
por: Galvano, Antonio, et al.
Publicado: (2019) -
Galvano-Therapeutics
Publicado: (1874) -
Galvano Therapeutics
Publicado: (1874) -
Neftel on Galvano-Therapeutics
Publicado: (1872)